MedPath

Effect of Tacrolimus in treatment of Recurrent Implantation Failure

Phase 3
Recruiting
Conditions
Recurrent Implantation Failure.
Registration Number
IRCT20240429061583N1
Lead Sponsor
Iranian academic center for education culture and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
162
Inclusion Criteria

Unexplained RIF
History of Three or more Failed Embryo Transfers

Exclusion Criteria

Patients who Used Immunosuppressive Drugs
Chronic Endometritis
Uterine Anomaly
Active Viral Diseases, Tuberculosis, Invasive Fungal Infections and Bacterial Infections
Patients with High Blood Pressure, Renal Failure, liver Disorder, Heart Failure, Ischemic Heart Disease , Arrhythmia, Untreated Endocrine Disorder
Immunocompromised Patients
Patients with Malignant Tumors
Patients with a history of Organ Transplantation
Patients with a history of Tacrolimus Allergy
Patients with a history of Blood Disorders, Coagulopathy
Antiphospholipid Syndrome and Collagen Vascular Disease
Patients receiving Potassium-Sparing Diuretics
Patients who received Live Vaccine 2 months before admission

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.